Risks, Benefits, and the Optimal Time to Resume Deep Vein Thrombosis Prophylaxis in Patients with Intracranial Hemorrhage

Introduction It is common to start all patients on chemical prophylaxis for deep vein thrombosis (DVT) in order to decrease the risk of venous thromboembolism (VTE) and the associated adverse effects, including the potential for fatal pulmonary embolism (PE). There is no consensus in the literature...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Cureus
Auteurs principaux: Farr, Saman, Toor, Harjyot, Patchana, Tye, Podkovik, Stacey, Wiginton, James G, Sweiss, Raed, Wacker, Margaret Rose, Miulli, Dan E
Format: Artigo
Langue:Inglês
Publié: Cureus 2019
Sujets:
Quality Improvement
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC6827698/
https://ncbi.nlm.nih.gov/pubmed/31754562
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7759/cureus.5827
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires